AI Generated Image
Millions of eye drops recalled. See list of affected products
USA Today • • business
Key Points:
- Over 12 million bottles of Rohto-brand over-the-counter eye drops have been recalled nationwide due to failure to meet FDA safety standards, specifically a lack of assurance of sterility.
- The recall, classified as class II by the FDA, indicates the products may cause temporary adverse effects but are unlikely to result in serious health issues.
- The recall affects eight types of Rohto eye drops, manufactured in Vietnam by Rohto-Mentholatum and distributed by the New York-based Mentholatum Company.
- Consumers are advised to stop using the recalled eye drops immediately and contact their local store regarding return options, as well as consult a doctor if concerned about health effects.
- The FDA enforcement report was issued following the recall initiated on July 14, with USA TODAY seeking comment from Mentholatum.
